Skip to content

Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.

Meta-analysis · Herz · 2025. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 39313691

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.

Baía Bezerra F, Rodrigues Sobreira LE, Tsuchiya Sano VK et al.
Herz · 2025

PubMed ID
39313691
Record checked

Linked publication notices

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.